- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: anti-PLA2R antibodies
Total 3774 results
-
Medical University of ViennaCompletedSystemic Inflammatory Response SyndromeAustria
-
Universita di VeronaUnknownChronic Plaque PsoriasisItaly
-
University of Mississippi Medical CenterNovartisCompleted
-
University of California, San FranciscoVicalCompletedCytomegalovirus InfectionUnited States
-
Federal University of São PauloCSL BehringCompletedCommon Variable Immunodeficiency | AgammaglobulinemiaBrazil
-
National Institute of Allergy and Infectious Diseases...Completed
-
Genitope CorporationTerminated
-
Biosynexus IncorporatedGlaxoSmithKlineCompletedStaphylococcal SepsisUnited States
-
Biosynexus IncorporatedGlaxoSmithKlineCompletedNeonatal Staphylococcal SepsisUnited States
-
National Institutes of Health Clinical Center (CC)CompletedAnthraxUnited States
-
National Eye Institute (NEI)Completed
-
National Institute of Neurological Disorders and...CompletedDemyelinating Diseases | ParaproteinemiasUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedRespiratory Syncytial Virus InfectionUnited States
-
National Institute of Arthritis and Musculoskeletal...CompletedSystemic Lupus ErythematosusUnited States
-
National Institute of Mental Health (NIMH)CompletedAutoimmune Diseases | Schizophrenia | Mental Disorders Diagnosed in ChildhoodUnited States
-
National Institute of Neurological Disorders and...CompletedSpinocerebellar DegenerationsUnited States
-
National Cancer Institute (NCI)CompletedLymphoma, T-Cell, Cutaneous | Leukemia, T-CellUnited States
-
National Institutes of Health Clinical Center (CC)Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedPurpura, Thrombocytopenic, Idiopathic | Immune Thrombocytopenic PurpuraUnited States
-
University of AarhusCompletedMultifocal Motor NeuropathyDenmark
-
NovartisCompletedRheumatoid ArthritisGermany, Netherlands, Switzerland
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFinland
-
BiogenCompleted
-
KU LeuvenCompleted
-
University of VirginiaNational Cancer Institute (NCI)Terminated
-
National Taiwan University HospitalCompleted
-
MedImmune LLCCambridge Antibody TechnologySuspendedLymphoma | LeukemiaUnited States
-
MedImmune LLCCompletedLupusUnited States, Canada
-
The University of Texas Health Science Center,...GlaxoSmithKlineCompletedHeparin-Induced ThrombocytopeniaUnited States
-
Mount Sinai Hospital, CanadaPfizer; Canadian Institutes of Health Research (CIHR)TerminatedRecurrent Pregnancy Loss | Antiphospholipid Antibody SyndromeCanada
-
Hospital de BaseUniversity of Sao PauloCompletedCoronary Artery Disease | Atherosclerosis | Chlamydia Infections | Mycoplasma Infections
-
Thrasher Research FundCenters for Disease Control and PreventionCompletedHIV Antibody TestingZambia
-
National Cancer Institute (NCI)CompletedMultiple Myeloma | Graft vs Host DiseaseUnited States
-
AbbottEisai LimitedCompleted
-
Daiichi Sankyo, Inc.CompletedLymphoma | MalignanciesUnited States
-
AbbottCompletedPsoriatic ArthritisUnited States
-
Tel-Aviv Sourasky Medical CenterUnknownPsoriatic Arthritis | Ankylosing Spondylitis | Undifferentiated Spondyloarthropathy
-
Cambridge Antibody TechnologyUnknownLeukemia | Non-Hodgkin's Lymphoma | NHLUnited States, Poland
-
Rockefeller UniversityCompleted
-
Millennium Pharmaceuticals, Inc.CompletedProstatic NeoplasmsUnited States
-
University of GiessenHoffmann-La Roche; Astellas Pharma Inc; Heidelberg University; Aventis PharmaceuticalsCompletedRenal Transplantation | Renal Failure, ChronicGermany
-
Hadassah Medical OrganizationUnknown
-
Lab Discoveries Ltd.Unknown
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
McGill UniversityMcGill University Health Centre/Research Institute of the McGill University...Unknown
-
Cubist Pharmaceuticals LLCTerminatedLiver Transplantation | Hepatitis BNew Zealand, United States, Israel, United Kingdom, France, Germany, Spain
-
Barwon HealthNational Health and Medical Research Council, Australia; University of MelbourneCompleted
-
BZL BiologicsCompletedPhase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2Prostatic NeoplasmsUnited States